📋 뉴스 브리핑
Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce.
원문 (English)
Novo Nordisk’s stock rallies after drugmaker reveals deal with OpenAI
Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce.
